New CAR T-Cell Therapy Approved for Leukemia

(MedPage Today) -- The FDA approved obecabtagene autoleucel (obe-cel; Aucatzyl) for treating relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in adults, the agency announced on Friday.
Of note, unlike other CAR T-cell...